MBX Biosciences, Inc. SEC filings MBX
MBX Biosciences, Inc. has 232 filings in SEC EDGAR's recent list, going back to May 10, 2019. Its latest annual report, Form ARS, was filed on Apr 22, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 6, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 22, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 4, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 5, 2026 | — |
| 144 | Notice of proposed sale | Nov 4, 2026 | — |
| 4 | Insider transaction | Oct 22, 2026 | Oct 20, 2026 |
| 3 | Initial insider ownership | Oct 22, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 22, 2026 | Oct 20, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 27, 2026 | Aug 27, 2026 |
| 144 | Notice of proposed sale | Aug 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 10, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 10, 2026 | — |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Aug 5, 2026 | Aug 4, 2026 |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 144 | Notice of proposed sale | Aug 4, 2026 | — |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| 4 | Insider transaction | Aug 4, 2026 | Aug 3, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jul 29, 2026 | — |
| 8-K |
Current report
Officer or director change
|
Jul 13, 2026 | Jul 9, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 8, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Jun 24, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 12, 2026 | Jun 12, 2026 |
| 144 | Notice of proposed sale | Jun 10, 2026 | — |
| 144 | Notice of proposed sale | Jun 9, 2026 | — |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 4 | Insider transaction | Jun 5, 2026 | Jun 4, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 5, 2026 | Jun 4, 2026 |
| 144 | Notice of proposed sale | May 13, 2026 | — |
| 4 | Insider transaction | May 11, 2026 | May 8, 2026 |
| 144 | Notice of proposed sale | May 11, 2026 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 11, 2026 | May 11, 2026 |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| DEFA14A | Additional proxy material | May 8, 2026 | — |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 4 | Insider transaction | May 8, 2026 | May 6, 2026 |
| 144 | Notice of proposed sale | May 8, 2026 | — |
| 144 | Notice of proposed sale | May 7, 2026 | — |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
| 10-Q | Quarterly report | May 7, 2026 | Mar 31, 2026 |
| 144 | Notice of proposed sale | May 6, 2026 | — |
| 144 | Notice of proposed sale | May 6, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 6, 2026 | — |
| 4 | Insider transaction | May 4, 2026 | May 1, 2026 |
| 144 | Notice of proposed sale | May 1, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 27, 2026 | — |
| 144 | Notice of proposed sale | Apr 22, 2026 | — |
| ARS | Annual report to shareholders | Apr 22, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 22, 2026 | — |
| DEF 14A | Proxy statement | Apr 22, 2026 | Apr 22, 2026 |
| 4/A | Filing | Apr 22, 2026 | Nov 22, 2025 |
| 4/A | Filing | Apr 22, 2026 | Nov 6, 2025 |
| 144 | Notice of proposed sale | Mar 25, 2026 | — |
| 3 | Initial insider ownership | Mar 18, 2026 | Mar 16, 2026 |
| 144 | Notice of proposed sale | Mar 16, 2026 | — |
| 4 | Insider transaction | Mar 16, 2026 | Mar 13, 2026 |
| S-3ASR | Automatic shelf registration | Mar 12, 2026 | — |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 9, 2026 | Mar 9, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Material agreement, Officer or director change
|
Feb 27, 2026 | Feb 24, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Feb 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 10, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 5, 2026 | Feb 4, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Feb 3, 2026 | Feb 2, 2026 |
| 4 | Insider transaction | Jan 22, 2026 | Jan 20, 2026 |
| 3 | Initial insider ownership | Jan 22, 2026 | Jan 20, 2026 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Jan 22, 2026 | Jan 20, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Jan 21, 2026 | — |
| 144 | Notice of proposed sale | Jan 12, 2026 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 12, 2026 | Jan 11, 2026 |
| EFFECT | Filing | Dec 8, 2025 | — |
| CORRESP | Letter to the SEC | Dec 4, 2025 | — |
| 4 | Insider transaction | Nov 25, 2025 | Nov 22, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 10, 2025 | — |
| 4 | Insider transaction | Nov 7, 2025 | Nov 6, 2025 |
| S-3 | Shelf registration | Nov 6, 2025 | — |
| 10-Q | Quarterly report | Nov 6, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Nov 6, 2025 | Oct 31, 2025 |
| 4 | Insider transaction | Oct 28, 2025 | Oct 24, 2025 |
| 4 | Insider transaction | Oct 21, 2025 | Oct 20, 2025 |
| 4 | Insider transaction | Oct 20, 2025 | Oct 17, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 6, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 30, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 30, 2025 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Sep 30, 2025 | — |
| 4 | Insider transaction | Sep 30, 2025 | Sep 26, 2025 |
| 8-K |
Current report
Material agreement
|
Sep 26, 2025 | Sep 24, 2025 |
| 424B4 | Prospectus | Sep 25, 2025 | — |
| EFFECT | Filing | Sep 24, 2025 | — |
| S-1MEF | Filing | Sep 24, 2025 | — |
| CORRESP | Letter to the SEC | Sep 22, 2025 | — |
| CORRESP | Letter to the SEC | Sep 22, 2025 | — |
| S-1 | Registration statement | Sep 22, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 22, 2025 | Sep 22, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 4, 2025 | Sep 4, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 20, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| DRS | Filing | Aug 8, 2025 | — |
| 10-Q | Quarterly report | Aug 7, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2025 | Aug 7, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 16, 2025 | Jun 16, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 9, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 4 | Insider transaction | Jun 6, 2025 | Jun 5, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 6, 2025 | Jun 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 10-Q | Quarterly report | May 12, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 12, 2025 | May 12, 2025 |
| ARS | Annual report to shareholders | Apr 23, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 23, 2025 | — |
| DEF 14A | Proxy statement | Apr 23, 2025 | Apr 22, 2025 |
| 4 | Insider transaction | Apr 10, 2025 | Apr 8, 2025 |
| 4 | Insider transaction | Apr 9, 2025 | Apr 7, 2025 |
| 3 | Initial insider ownership | Apr 7, 2025 | Apr 7, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 7, 2025 | Apr 7, 2025 |
| S-8 | Employee stock plan registration | Mar 17, 2025 | — |
| 10-K | Annual report | Mar 17, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 17, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 19, 2025 | Feb 14, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 4 | Insider transaction | Feb 5, 2025 | Feb 3, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure, Other events
|
Jan 7, 2025 | Jan 7, 2025 |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 1, 2024 | — |
| SC 13D | Ownership over 5% (active) | Sep 23, 2024 | — |
| SC 13D | Ownership over 5% (active) | Sep 23, 2024 | — |
| SC 13D | Ownership over 5% (active) | Sep 23, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Sep 23, 2024 | — |
| SC 13D | Ownership over 5% (active) | Sep 23, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Sep 20, 2024 | — |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 17, 2024 | Sep 16, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Sep 16, 2024 | Sep 16, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| 4 | Insider transaction | Sep 13, 2024 | Sep 12, 2024 |
| S-8 | Employee stock plan registration | Sep 13, 2024 | — |
| 424B5 | Prospectus supplement | Sep 13, 2024 | — |
| EFFECT | Filing | Sep 12, 2024 | — |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
| 3 | Initial insider ownership | Sep 12, 2024 | Sep 12, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MBX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carmel, IN
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1776111
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.